Literature DB >> 19498344

Health outcomes of gastric bypass patients compared to nonsurgical, nonintervened severely obese.

Ted D Adams1, Robert C Pendleton, Michael B Strong, Ronette L Kolotkin, James M Walker, Sheldon E Litwin, Wael K Berjaoui, Michael J LaMonte, Tom V Cloward, Erick Avelar, Theophilus E Owan, Robert T Nuttall, Richard E Gress, Ross D Crosby, Paul N Hopkins, Eliot A Brinton, Wayne D Rosamond, Gail A Wiebke, Frank G Yanowitz, Robert J Farney, R Chad Halverson, Steven C Simper, Sherman C Smith, Steven C Hunt.   

Abstract

Favorable health outcomes at 2 years postbariatric surgery have been reported. With exception of the Swedish Obesity Subjects (SOS) study, these studies have been surgical case series, comparison of surgery types, or surgery patients compared to subjects enrolled in planned nonsurgical intervention. This study measured gastric bypass effectiveness when compared to two separate severely obese groups not participating in designed weight-loss intervention. Three groups of severely obese subjects (N = 1,156, BMI >or= 35 kg/m(2)) were studied: gastric bypass subjects (n = 420), subjects seeking gastric bypass but did not have surgery (n = 415), and population-based subjects not seeking surgery (n = 321). Participants were studied at baseline and 2 years. Quantitative outcome measures as well as prevalence, incidence, and resolution rates of categorical health outcome variables were determined. All quantitative variables (BMI, blood pressure, lipids, diabetes-related variables, resting metabolic rate (RMR), sleep apnea, and health-related quality of life) improved significantly in the gastric bypass group compared with each comparative group (all P < 0.0001, except for diastolic blood pressure and the short form (SF-36) health survey mental component score at P < 0.01). Diabetes, dyslipidemia, and hypertension resolved much more frequently in the gastric bypass group than in the comparative groups (all P < 0.001). In the surgical group, beneficial changes of almost all quantitative variables correlated significantly with the decrease in BMI. We conclude that Roux-en-Y gastric bypass surgery when compared to severely obese groups not enrolled in planned weight-loss intervention was highly effective for weight loss, improved health-related quality of life, and resolution of major obesity-associated complications measured at 2 years.

Entities:  

Mesh:

Year:  2009        PMID: 19498344      PMCID: PMC2864142          DOI: 10.1038/oby.2009.178

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN: 1930-7381            Impact factor:   5.002


  31 in total

Review 1.  Flaws in methods of evidence-based medicine may adversely affect public health directives.

Authors:  J G Kral; J B Dixon; F F Horber; S Rössner; S Stiles; J S Torgerson; H J Sugerman
Journal:  Surgery       Date:  2005-03       Impact factor: 3.982

2.  National trends in utilization and outcomes of bariatric surgery.

Authors:  T L Trus; G D Pope; S R G Finlayson
Journal:  Surg Endosc       Date:  2005-03-11       Impact factor: 4.584

3.  Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery.

Authors:  Lars Sjöström; Anna-Karin Lindroos; Markku Peltonen; Jarl Torgerson; Claude Bouchard; Björn Carlsson; Sven Dahlgren; Bo Larsson; Kristina Narbro; Carl David Sjöström; Marianne Sullivan; Hans Wedel
Journal:  N Engl J Med       Date:  2004-12-23       Impact factor: 91.245

Review 4.  Potential of surgery for curing type 2 diabetes mellitus.

Authors:  Francesco Rubino; Michel Gagner
Journal:  Ann Surg       Date:  2002-11       Impact factor: 12.969

5.  Design and rationale of the Utah obesity study. A study to assess morbidity following gastric bypass surgery.

Authors:  Ted D Adams; Erick Avelar; Tom Cloward; Ross D Crosby; Robert J Farney; Richard Gress; R Chad Halverson; Paul N Hopkins; Ronette L Kolotkin; Michael J Lamonte; Sheldon Litwin; Robert T Nuttall; Robert Pendleton; Wayne Rosamond; Steven C Simper; Sherman C Smith; Michael Strong; James M Walker; Gail Wiebke; Frank G Yanowitz; Steven C Hunt
Journal:  Contemp Clin Trials       Date:  2005-10       Impact factor: 2.226

6.  Meta-analysis: surgical treatment of obesity.

Authors:  Melinda A Maggard; Lisa R Shugarman; Marika Suttorp; Margaret Maglione; Harvey J Sugerman; Harvey J Sugarman; Edward H Livingston; Ninh T Nguyen; Zhaoping Li; Walter A Mojica; Lara Hilton; Shannon Rhodes; Sally C Morton; Paul G Shekelle
Journal:  Ann Intern Med       Date:  2005-04-05       Impact factor: 25.391

Review 7.  Extreme obesity: a new medical crisis in the United States.

Authors:  Donald D Hensrud; Samuel Klein
Journal:  Mayo Clin Proc       Date:  2006-10       Impact factor: 7.616

8.  A comparison of positive family history definitions for defining risk of future disease.

Authors:  S C Hunt; R R Williams; G K Barlow
Journal:  J Chronic Dis       Date:  1986

9.  Swedish obese subjects (SOS). Recruitment for an intervention study and a selected description of the obese state.

Authors:  L Sjöström; B Larsson; L Backman; C Bengtsson; C Bouchard; S Dahlgren; P Hallgren; E Jonsson; J Karlsson; L Lapidus
Journal:  Int J Obes Relat Metab Disord       Date:  1992-06

10.  Open vs laparoscopic Roux-en-Y gastric bypass: comparison of operative morbidity and mortality.

Authors:  Sherman C Smith; Charles B Edwards; Gerald N Goodman; R Chad Halversen; Steven C Simper
Journal:  Obes Surg       Date:  2004-01       Impact factor: 4.129

View more
  51 in total

Review 1.  Reductions in cardiovascular risk after bariatric surgery.

Authors:  Fethi Benraouane; Sheldon E Litwin
Journal:  Curr Opin Cardiol       Date:  2011-11       Impact factor: 2.161

2.  Improved heart rate recovery after marked weight loss induced by gastric bypass surgery: two-year follow up in the Utah Obesity Study.

Authors:  Stephen L Wasmund; Theophilus Owan; Frank G Yanowitz; Ted D Adams; Steven C Hunt; Mohamed H Hamdan; Sheldon E Litwin
Journal:  Heart Rhythm       Date:  2010-10-20       Impact factor: 6.343

3.  Four-year hospital resource utilization after bariatric surgery: comparison with clinical and surgical controls.

Authors:  Silvia Yoko Hayashi; Joel Faintuch; Joao Italo Dias França; Ivan Cecconello
Journal:  Obes Surg       Date:  2011-09       Impact factor: 4.129

4.  Exploring Partners' Experiences in Living with Patients Who Undergo Bariatric Surgery.

Authors:  Anna Wallwork; Lynn Tremblay; Monica Chi; Sanjeev Sockalingam
Journal:  Obes Surg       Date:  2017-08       Impact factor: 4.129

Review 5.  Quality of life and bariatric surgery: a systematic review of short- and long-term results and comparison with community norms.

Authors:  L C H Raaijmakers; S Pouwels; S E M Thomassen; S W Nienhuijs
Journal:  Eur J Clin Nutr       Date:  2016-11-02       Impact factor: 4.016

6.  Immune cell-mediated inflammation and the early improvements in glucose metabolism after gastric banding surgery.

Authors:  Katherine Samaras; Alexander Viardot; Natalia K Botelho; Alicia Jenkins; Reginald V Lord
Journal:  Diabetologia       Date:  2013-09-13       Impact factor: 10.122

7.  Changes in Hematology and Calcium Metabolism After Gastric Bypass Surgery--a 2-Year Follow-Up Study.

Authors:  Dorte Worm; Sten Madsbad; Viggo B Kristiansen; Lars Naver; Dorte Lindqvist Hansen
Journal:  Obes Surg       Date:  2015-09       Impact factor: 4.129

Review 8.  Gastrointestinal surgery: cardiovascular risk reduction and improved long-term survival in patients with obesity and diabetes.

Authors:  Ted D Adams; Lance E Davidson; Sheldon E Litwin; Steven C Hunt
Journal:  Curr Atheroscler Rep       Date:  2012-12       Impact factor: 5.113

9.  Gut microbiota differs a decade after bariatric surgery relative to a nonsurgical comparison group.

Authors:  Jacob G Mabey; John M Chaston; Daphne G Castro; Ted D Adams; Steven C Hunt; Lance E Davidson
Journal:  Surg Obes Relat Dis       Date:  2020-04-18       Impact factor: 4.734

Review 10.  Quality of Life Outcomes of Bariatric Surgery: A Systematic Review.

Authors:  Aleeya Hachem; Leah Brennan
Journal:  Obes Surg       Date:  2016-02       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.